Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Myasthenia Gravis
NCT00814138Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Apr 2009
- Primary completion
- Jan 2014
- Countries
- 2
01
Overview
A Phase 2 trial of methotrexate in myasthenia gravis (MG), sponsored by University of Kansas Medical Center. Started Apr 2009; status: completed.
02
Drugs
methotrexate
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00814138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814138.